Global Wet Age Related Macular Degeneration Market Growth 2018-2023

Global Wet Age Related Macular Degeneration Market Growth 2018-2023

Category

Pharmaceuticals

Published Date

18th Oct 2018

Pages

138

Choose License

Final Price

Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally.
Increased awareness among people about the condition has influenced the AMD treatment global demand. At the same time, the arrival of off-patent blockbuster drugs is reflecting favorably on the market particularly in third-world countries. This has allowed small-scale drug manufactures to penetrate untapped markets.

According to this study, over the next five years the Wet Age Related Macular Degeneration (AMD) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global revenue market share of key companies in Wet Age Related Macular Degeneration (AMD) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Wet Age Related Macular Degeneration (AMD) market by product type, application, key companies and key regions.

This study considers the Wet Age Related Macular Degeneration (AMD) value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 10.7.
Wet Age-Related Macular Degeneration (Wet AMD)
Dry Age-Related Macular Degeneration (Dry AMD)
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 10.8.
>75 Years 
>60 Years 
>40 Years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis International (Switzerland)
Bayer (Germany)
Acucela (U.S.)
Neurotech Pharmaceuticals (U.S.)
Ophthotech (U.S.)
GlaxoSmithKline (U.S.)
Alimera Sciences (U.S.)
StemCell (Canada)
F. Hoffmann-La Roche (Switzerland)
Regeneron Pharmaceutical (U.S.)
Allergan (Ireland)
Adverum Biotechnologies (U.S.)
Gilead Sciences (U.S.)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Wet Age Related Macular Degeneration (AMD) market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Wet Age Related Macular Degeneration (AMD) market by identifying its various subsegments.
Focuses on the key global Wet Age Related Macular Degeneration (AMD) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Wet Age Related Macular Degeneration (AMD) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Wet Age Related Macular Degeneration (AMD) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

2018-2023 Global Wet Age Related Macular Degeneration (AMD) Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Wet Age Related Macular Degeneration (AMD) Market Size 2013-2023
2.1.2 Wet Age Related Macular Degeneration (AMD) Market Size CAGR by Region
2.2 Wet Age Related Macular Degeneration (AMD) Segment by Type
2.2.1 Wet Age-Related Macular Degeneration (Wet AMD)
2.2.2 Dry Age-Related Macular Degeneration (Dry AMD)
2.3 Wet Age Related Macular Degeneration (AMD) Market Size by Type
2.3.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)
2.3.2 Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (2013-2018)
2.4 Wet Age Related Macular Degeneration (AMD) Segment by Application
2.4.1 >75 Years 
2.4.2 >60 Years 
2.4.3 >40 Years
2.5 Wet Age Related Macular Degeneration (AMD) Market Size by Application
2.5.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)
2.5.2 Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Application (2013-2018)

3 Global Wet Age Related Macular Degeneration (AMD) by Players
3.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Players
3.1.1 Global Wet Age Related Macular Degeneration (AMD) Market Size by Players (2016-2018)
3.1.2 Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Players (2016-2018)
3.2 Global Wet Age Related Macular Degeneration (AMD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Wet Age Related Macular Degeneration (AMD) by Regions
4.1 Wet Age Related Macular Degeneration (AMD) Market Size by Regions
4.2 Americas Wet Age Related Macular Degeneration (AMD) Market Size Growth
4.3 APAC Wet Age Related Macular Degeneration (AMD) Market Size Growth
4.4 Europe Wet Age Related Macular Degeneration (AMD) Market Size Growth
4.5 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size Growth

5 Americas
5.1 Americas Wet Age Related Macular Degeneration (AMD) Market Size by Countries
5.2 Americas Wet Age Related Macular Degeneration (AMD) Market Size by Type
5.3 Americas Wet Age Related Macular Degeneration (AMD) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Wet Age Related Macular Degeneration (AMD) Market Size by Countries
6.2 APAC Wet Age Related Macular Degeneration (AMD) Market Size by Type
6.3 APAC Wet Age Related Macular Degeneration (AMD) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Wet Age Related Macular Degeneration (AMD) by Countries
7.2 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type
7.3 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Wet Age Related Macular Degeneration (AMD) by Countries
8.2 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type
8.3 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Wet Age Related Macular Degeneration (AMD) Market Forecast
10.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2018-2023)
10.2 Global Wet Age Related Macular Degeneration (AMD) Forecast by Regions
10.2.1 Global Wet Age Related Macular Degeneration (AMD) Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Wet Age Related Macular Degeneration (AMD) Forecast by Type
10.8 Global Wet Age Related Macular Degeneration (AMD) Forecast by Application

11 Key Players Analysis
11.1 Novartis International (Switzerland)
11.1.1 Company Details
11.1.2 Wet Age Related Macular Degeneration (AMD) Product Offered
11.1.3 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Novartis International (Switzerland) News
11.2 Bayer (Germany)
11.2.1 Company Details
11.2.2 Wet Age Related Macular Degeneration (AMD) Product Offered
11.2.3 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Bayer (Germany) News
11.3 Acucela (U.S.)
11.3.1 Company Details
11.3.2 Wet Age Related Macular Degeneration (AMD) Product Offered
11.3.3 Acucela (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Acucela (U.S.) News
11.4 Neurotech Pharmaceuticals (U.S.)
11.4.1 Company Details
11.4.2 Wet Age Related Macular Degeneration (AMD) Product Offered
11.4.3 Neurotech Pharmaceuticals (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Neurotech Pharmaceuticals (U.S.) News
11.5 Ophthotech (U.S.)
11.5.1 Company Details
11.5.2 Wet Age Related Macular Degeneration (AMD) Product Offered
11.5.3 Ophthotech (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Ophthotech (U.S.) News
11.6 GlaxoSmithKline (U.S.)
11.6.1 Company Details
11.6.2 Wet Age Related Macular Degeneration (AMD) Product Offered
11.6.3 GlaxoSmithKline (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 GlaxoSmithKline (U.S.) News
11.7 Alimera Sciences (U.S.)
11.7.1 Company Details
11.7.2 Wet Age Related Macular Degeneration (AMD) Product Offered
11.7.3 Alimera Sciences (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Alimera Sciences (U.S.) News
11.8 StemCell (Canada)
11.8.1 Company Details
11.8.2 Wet Age Related Macular Degeneration (AMD) Product Offered
11.8.3 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 StemCell (Canada) News
11.9 F. Hoffmann-La Roche (Switzerland)
11.9.1 Company Details
11.9.2 Wet Age Related Macular Degeneration (AMD) Product Offered
11.9.3 F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 F. Hoffmann-La Roche (Switzerland) News
11.10 Regeneron Pharmaceutical (U.S.)
11.10.1 Company Details
11.10.2 Wet Age Related Macular Degeneration (AMD) Product Offered
11.10.3 Regeneron Pharmaceutical (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Regeneron Pharmaceutical (U.S.) News
11.11 Allergan (Ireland)
11.12 Adverum Biotechnologies (U.S.)
11.13 Gilead Sciences (U.S.)

12 Research Findings and Conclusion
List of Tables and Figures_x000D_
_x000D_
Table Product Specifications of Wet Age Related Macular Degeneration (AMD)_x000D_
Figure Wet Age Related Macular Degeneration (AMD) Report Years Considered_x000D_
Figure Market Research Methodology_x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate 2013-2023 ($ Millions)_x000D_
Table Wet Age Related Macular Degeneration (AMD) Market Size CAGR by Region 2013-2023 ($ Millions)_x000D_
Table Major Players of Wet Age-Related Macular Degeneration (Wet AMD)_x000D_
Table Major Players of Dry Age-Related Macular Degeneration (Dry AMD)_x000D_
Table Market Size by Type (2013-2018) ($ Millions)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)_x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)_x000D_
Figure Global Wet Age-Related Macular Degeneration (Wet AMD) Market Size Growth Rate_x000D_
Figure Global Dry Age-Related Macular Degeneration (Dry AMD) Market Size Growth Rate_x000D_
Figure Wet Age Related Macular Degeneration (AMD) Consumed in >75 Years _x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) Market: >75 Years  (2013-2018) ($ Millions)_x000D_
Figure Global >75 Years  YoY Growth ($ Millions)_x000D_
Figure Wet Age Related Macular Degeneration (AMD) Consumed in >60 Years _x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) Market: >60 Years  (2013-2018) ($ Millions)_x000D_
Figure Global >60 Years  YoY Growth ($ Millions)_x000D_
Figure Wet Age Related Macular Degeneration (AMD) Consumed in >40 Years_x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) Market: >40 Years (2013-2018) ($ Millions)_x000D_
Figure Global >40 Years YoY Growth ($ Millions)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2013-2018) ($ Millions)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)_x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)_x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size in >75 Years  Growth Rate_x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size in >60 Years  Growth Rate_x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size in >40 Years Growth Rate_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Revenue by Players (2016-2018) ($ Millions)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2016-2018)_x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Players in 2017_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Key Players Head office and Products Offered_x000D_
Table Wet Age Related Macular Degeneration (AMD) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions 2013-2018 ($ Millions)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Regions 2013-2018_x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Regions 2013-2018_x000D_
Figure Americas Wet Age Related Macular Degeneration (AMD) Market Size 2013-2018 ($ Millions)_x000D_
Figure APAC Wet Age Related Macular Degeneration (AMD) Market Size 2013-2018 ($ Millions)_x000D_
Figure Europe Wet Age Related Macular Degeneration (AMD) Market Size 2013-2018 ($ Millions)_x000D_
Figure Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size 2013-2018 ($ Millions)_x000D_
Table Americas Wet Age Related Macular Degeneration (AMD) Market Size by Countries (2013-2018) ($ Millions)_x000D_
Table Americas Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Countries (2013-2018)_x000D_
Figure Americas Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Countries in 2017_x000D_
Table Americas Wet Age Related Macular Degeneration (AMD) Market Size by Type (2013-2018) ($ Millions)_x000D_
Table Americas Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)_x000D_
Figure Americas Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2017_x000D_
Table Americas Wet Age Related Macular Degeneration (AMD) Market Size by Application (2013-2018) ($ Millions)_x000D_
Table Americas Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)_x000D_
Figure Americas Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2017_x000D_
Figure United States Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Canada Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Mexico Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Table APAC Wet Age Related Macular Degeneration (AMD) Market Size by Countries (2013-2018) ($ Millions)_x000D_
Table APAC Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Countries (2013-2018)_x000D_
Figure APAC Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Countries in 2017_x000D_
Table APAC Wet Age Related Macular Degeneration (AMD) Market Size by Type (2013-2018) ($ Millions)_x000D_
Table APAC Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)_x000D_
Figure APAC Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2017_x000D_
Table APAC Wet Age Related Macular Degeneration (AMD) Market Size by Application (2013-2018) ($ Millions)_x000D_
Table APAC Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)_x000D_
Figure APAC Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2017_x000D_
Figure China Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Japan Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Korea Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure India Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Australia Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Table Europe Wet Age Related Macular Degeneration (AMD) Market Size by Countries (2013-2018) ($ Millions)_x000D_
Table Europe Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Countries (2013-2018)_x000D_
Figure Europe Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Countries in 2017_x000D_
Table Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2013-2018) ($ Millions)_x000D_
Table Europe Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)_x000D_
Figure Europe Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2017_x000D_
Table Europe Wet Age Related Macular Degeneration (AMD) Market Size by Application (2013-2018) ($ Millions)_x000D_
Table Europe Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)_x000D_
Figure Europe Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2017_x000D_
Figure Germany Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure France Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure UK Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Italy Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Russia Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Spain Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Table Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Countries (2013-2018) ($ Millions)_x000D_
Table Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Countries (2013-2018)_x000D_
Figure Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Countries in 2017_x000D_
Table Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type (2013-2018) ($ Millions)_x000D_
Table Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)_x000D_
Figure Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2017_x000D_
Table Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Application (2013-2018) ($ Millions)_x000D_
Table Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)_x000D_
Figure Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2017_x000D_
Figure Egypt Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure South Africa Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Israel Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Turkey Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure GCC Countries Wet Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Global Wet Age Related Macular Degeneration (AMD) arket Size Forecast (2018-2023) ($ Millions)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Forecast by Regions (2018-2023) ($ Millions)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Regions_x000D_
Figure Americas Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure APAC Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Europe Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure United States Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Canada Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Mexico Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Brazil Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure China Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Japan Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Korea Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure India Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Australia Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Germany Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure France Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure UK Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Italy Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Russia Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Spain Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Egypt Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure South Africa Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Israel Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure Turkey Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Figure GCC Countries Wet Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Forecast by Type (2018-2023) ($ Millions)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Type (2018-2023)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Forecast by Application (2018-2023) ($ Millions)_x000D_
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Application (2018-2023)_x000D_
Table Novartis International (Switzerland) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)_x000D_
Figure Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Market Share (2016-2018)_x000D_
Table Bayer (Germany) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)_x000D_
Figure Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Market Share (2016-2018)_x000D_
Table Acucela (U.S.) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Acucela (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)_x000D_
Figure Acucela (U.S.) Wet Age Related Macular Degeneration (AMD) Market Share (2016-2018)_x000D_
Table Neurotech Pharmaceuticals (U.S.) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Neurotech Pharmaceuticals (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)_x000D_
Figure Neurotech Pharmaceuticals (U.S.) Wet Age Related Macular Degeneration (AMD) Market Share (2016-2018)_x000D_
Table Ophthotech (U.S.) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Ophthotech (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)_x000D_
Figure Ophthotech (U.S.) Wet Age Related Macular Degeneration (AMD) Market Share (2016-2018)_x000D_
Table GlaxoSmithKline (U.S.) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table GlaxoSmithKline (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)_x000D_
Figure GlaxoSmithKline (U.S.) Wet Age Related Macular Degeneration (AMD) Market Share (2016-2018)_x000D_
Table Alimera Sciences (U.S.) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Alimera Sciences (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)_x000D_
Figure Alimera Sciences (U.S.) Wet Age Related Macular Degeneration (AMD) Market Share (2016-2018)_x000D_
Table StemCell (Canada) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)_x000D_
Figure StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Market Share (2016-2018)_x000D_
Table F. Hoffmann-La Roche (Switzerland) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)_x000D_
Figure F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Market Share (2016-2018)_x000D_
Table Regeneron Pharmaceutical (U.S.) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Regeneron Pharmaceutical (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)_x000D_
Figure Regeneron Pharmaceutical (U.S.) Wet Age Related Macular Degeneration (AMD) Market Share (2016-2018)_x000D_
Table Allergan (Ireland) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Adverum Biotechnologies (U.S.) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Gilead Sciences (U.S.) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us